Ticker Details
AN2 Therapeutics, Inc.
IPO Date:	March 25, 2022
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$219.25M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.35 | 4.62%
Avg Daily Range (30 D):	$0.13 | 2.43%
Avg Daily Range (90 D):	$0.18 | 4.11%

Institutional Daily Volume
Avg Daily Volume:	.24M
Avg Daily Volume (30 D):	.16M
Avg Daily Volume (90 D):	.22M

Trade Size
Avg Trade Size (Sh.):	174
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	87

Institutional Trades
Total Institutional Trades:	60
Avg Institutional Trade:	$1.87M
Avg Institutional Trade (30 D):	$4.81M
Avg Institutional Trade (90 D):	$2.85M
Avg Institutional Trade Volume:	.42M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.86M
Avg Closing Trade (30 D):	$12.17M
Avg Closing Trade (90 D):	$4.67M
Avg Closing Volume:	352.16K

News

May 21, 2024 @ 1:35 PM Down -5.51% in 4 Weeks, Here's Why AN2 Therapeutic... Source: Zacks Equity Research

Feb 13, 2024 @ 1:08 PM ZoomInfo Technologies To Rally Around 50%? Here Ar... Source: Avi Kapoor

Feb 12, 2024 @ 7:15 PM Nasdaq Edges Lower; ContextLogic Shares Surge Source: Avi Kapoor

Feb 12, 2024 @ 6:07 PM Why Big Lots Shares Are Trading Lower By Around 31... Source: Avi Kapoor

Feb 12, 2024 @ 5:30 PM Dow Surges Over 150 Points; Gilead Sciences To Acq... Source: Avi Kapoor

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS		$-.18	$-.29
Diluted EPS		$-.18	$-.29
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-8.19M	$-10.03M
Operating Income / Loss		$-8.9M	$-10.55M
Cost of Revenue
Net Cash Flow		$-9.17M	$33.55M
PE Ratio